Answer
Nov 19, 2025 - 12:07 PM
Leqembi is controversial because, while it shows some effectiveness in slowing cognitive decline in early Alzheimer's disease, its benefits are modest and come with significant risks, such as brain swelling and bleeding. Additionally, its high cost and the need for regular infusions raise questions about accessibility and overall value for patients.
